Department of Urology, University Hospital Charité, Berlin, Germany.
Int J Biol Sci. 2012;8(10):1363-74. doi: 10.7150/ijbs.5106. Epub 2012 Oct 28.
MicroRNAs (miRNAs) play a pivotal role in cancerogenesis and cancer progression, but their specific role in the metastasis of clear cell renal cell carcinomas (ccRCC) is still limited. Based on microRNA microarray analyses from normal and cancerous samples of ccRCC specimens and from bone metastases of ccRCC patients, we identified a set of 57 differentially expressed microRNAs between these three sample groups of ccRCC. A selected panel of 33 miRNAs was subsequently validated by RT-qPCR on total 57 samples. Then, 30 of the 33 examined miRNAs were confirmed to be deregulated. A stepwise down-regulation of miRNA expression from normal, over primary tumor to metastatic tissue samples, was found to be typical. A total of 23 miRNAs (miR-10b/-19a/-19b/-20a/-29a/-29b/-29c/-100/-101/-126/-127/-130/-141/-143/-145/-148a/-192/-194/-200c/-210/-215/-370/-514) were down-regulated in metastatic tissue samples compared with normal tissue. This down-regulated expression in metastatic tissue in comparison with primary tumor tissue was also present in 21 miRNAs. In cell culture experiments with 5-aza-2'-deoxycytidine and trichostatin A, epigenetic modifications were shown as one reason of this down-regulation. The altered miRNA profiles, comprising newly identified metastasis-associated miRNAs, termed metastamir and the predicted miRNA-target interactions together with the significant correlations of miRNAs that were either lost or newly appeared in the studied sample groups, afford a solid basis for further functional analyses of individual miRNAs in RCC metastatic progression.
微小 RNA(miRNAs)在癌症发生和癌症进展中发挥着关键作用,但它们在透明细胞肾细胞癌(ccRCC)转移中的具体作用仍有限。基于 ccRCC 标本正常和癌组织以及 ccRCC 患者骨转移组织的 miRNA 微阵列分析,我们鉴定出这三组 ccRCC 样本间存在 57 个差异表达的 miRNA。随后,通过 RT-qPCR 在总共 57 个样本上验证了一个选择的 33 个 miRNA 面板。接着,33 个检查 miRNA 中有 30 个被证实存在失调。从正常组织、原发性肿瘤到转移性组织样本的 miRNA 表达逐渐下调是典型的。总共 23 个 miRNA(miR-10b/-19a/-19b/-20a/-29a/-29b/-29c/-100/-101/-126/-127/-130/-141/-143/-145/-148a/-192/-194/-200c/-210/-215/-370/-514)在转移性组织样本中下调,与正常组织相比。与原发性肿瘤组织相比,这种在转移性组织中的下调表达也存在于 21 个 miRNA 中。在 5-氮杂-2'-脱氧胞苷和曲古抑菌素 A 的细胞培养实验中,表观遗传修饰被证明是这种下调的一个原因。改变的 miRNA 谱,包括新鉴定的与转移相关的 miRNA,称为 metastamir 和预测的 miRNA-靶相互作用,以及在研究的样本组中丢失或新出现的 miRNA 的显著相关性,为进一步研究 RCC 转移进展中单个 miRNA 的功能提供了坚实的基础。